Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens

In English

Författare

  • Frank Wegmann
  • Kate H. Gartlan
  • Ali M. Harandi
  • Sarah A. Brinckmann
  • Margherita Coccia
  • William R. Hillson
  • Wai Ling Kok
  • Suzanne Cole
  • Ling-Pei Ho
  • Teresa Lambe
  • Manoj Puthia
  • Catharina Svanborg
  • Erin M. Scherer
  • George Krashias
  • Adam Williams
  • Joseph N. Blattman
  • Philip D. Greenberg
  • Richard A. Flavell
  • Amin E. Moghaddam
  • Neil C. Sheppard
  • Quentin J. Sattentau
Visa allt

Summary, in English

Protection against mucosally transmitted infections probably requires immunity at the site of pathogen entry(1), yet there are no mucosal adjuvant formulations licensed for human use. Polyethyleneimine (PEI) represents a family of organic polycations used as nucleic acid transfection reagents in vitro and DNA vaccine delivery vehicles in vivo(2,3). Here we show that diverse PEI forms have potent mucosal adjuvant activity for viral subunit glycoprotein antigens. A single intranasal administration of influenza hemagglutinin or herpes simplex virus type-2 (HSV-2) glycoprotein D with PEI elicited robust antibody-mediated protection from an otherwise lethal infection, and was superior to existing experimental mucosal adjuvants. PEI formed nanoscale complexes with antigen, which were taken up by antigen-presenting cells in vitro and in vivo, promoted dendritic cell trafficking to draining lymph nodes and induced non-proinflammatory cytokine responses. PEI adjuvanticity required release of host double-stranded DNA that triggered Irf3-dependent signaling. PEI therefore merits further investigation as a mucosal adjuvant for human use.

Publiceringsår

2012

Språk

Engelska

Sidor

883-888

Publikation/Tidskrift/Serie

Nature Biotechnology

Volym

30

Issue

9

Dokumenttyp

Artikel i tidskrift

Förlag

Nature Publishing Group

Ämne

  • Microbiology in the medical area
  • Immunology in the medical area

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 1546-1696